✦ LIBER ✦

PCV70 A PHARMACOECONOMIC COMPARISON OF UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN USAGE IN ACUTE CORONARY SYNDROME IN RUSSIA

✍ Scribed by LB Lazebnik; NA Kuznetsova; AV Gavrilova; VP Komarova

Book ID: 119592635
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 68 KB
Volume: 6
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)61714-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-Molecular-Weight Heparin Should Repl

Low-Molecular-Weight Heparin Should Replace Unfractionated Heparin in the Management of Acute Coronary Syndromes

✍ Peter J. Zed 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 98 KB

Unfractionated heparin and low-molecular

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis

✍ John W Eikelboom; Sonia S Anand; Klas Malmberg; Jeffrey I Weitz; Jeffrey S Ginsb 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 103 KB

Superior efficacy of low-molecular-weigh

Superior efficacy of low-molecular-weight heparin vs unfractionated heparin in acute coronary syndrome without ST elevation

✍ F Aslam 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Superior efficacy of low molecular weigh

Superior efficacy of low molecular weight heparin versus unfractionated heparin in acute coronary syndromes without ST elevation

✍ Thibaud Damy; Anissa Bouzamondo; Gilles Montalescot; Philippe Lechat 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Low molecular weight heparin in acute co

Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?

✍ Sanjay Kaul; Prediman K Shah 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Low-molecular-weight heparin vs. unfract

Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: A combined analysis

✍ Maria Borentain; Gilles Montalescot; Anissa Bouzamondo; Rémi Choussat; Jean-Séba 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract This meta‐analysis assessed the rates of the efficacy and safety endpoints with intravenous low‐molecular‐weight heparin (LMWH) compared with unfractionated heparin (UFH) in patients undergoing percutaneous coronary intervention (PCI). Subcutaneous LMWH has compared favorably with UFH,